ProMIS Neurosciences Has Selected The Lead Vaccine Candidate, PMN400, Against Multiple Synucleinopathies Including Multiple System Atrophy, Parkinson's Disease And Lewy Body Dementia
ProMis Neurosciences 已選擇主要候選疫苗 PMN400,以對抗多種突觸核病,包括多系統萎縮、帕金森氏病和路易體癡呆